These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 8563891)

  • 1. Immune response modulation in inflammatory bowel diseases by
    Feilstrecker Balani G; Dos Santos Cortez M; Picasky da Silveira Freitas JE; Freire de Melo F; Zarpelon-Schutz AC; Teixeira KN
    World J Gastroenterol; 2023 Aug; 29(30):4604-4615. PubMed ID: 37662864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Importance of Hypoxia-Inducible Factors (HIF-1 and HIF-2) for the Pathophysiology of Inflammatory Bowel Disease.
    Kerber EL; Padberg C; Koll N; Schuetzhold V; Fandrey J; Winning S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Utilization of Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids Using Microengineered Chips.
    Workman MJ; Gleeson JP; Troisi EJ; Estrada HQ; Kerns SJ; Hinojosa CD; Hamilton GA; Targan SR; Svendsen CN; Barrett RJ
    Cell Mol Gastroenterol Hepatol; 2018; 5(4):669-677.e2. PubMed ID: 29930984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease-related arthritis - clinical evaluation and possible role of cytokines.
    Dmowska-Chalaba J; Kontny E
    Reumatologia; 2015; 53(5):236-42. PubMed ID: 27407253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules.
    Radhakrishnan VM; Kojs P; Ramalingam R; Midura-Kiela MT; Angeli P; Kiela PR; Ghishan FK
    J Biol Chem; 2015 Apr; 290(14):8964-74. PubMed ID: 25648899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathology of inflammatory bowel disease.
    Wallace KL; Zheng LB; Kanazawa Y; Shih DQ
    World J Gastroenterol; 2014 Jan; 20(1):6-21. PubMed ID: 24415853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel genetic markers in inflammatory bowel disease.
    Rodriguez-Bores L; Fonseca GC; Villeda MA; Yamamoto-Furusho JK
    World J Gastroenterol; 2007 Nov; 13(42):5560-70. PubMed ID: 17948929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.
    Ito R; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Kita M; Ueda Y; Iwakura Y; Kataoka K; Okanoue T; Mazda O
    Clin Exp Immunol; 2006 Nov; 146(2):330-8. PubMed ID: 17034586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane.
    Utech M; Ivanov AI; Samarin SN; Bruewer M; Turner JR; Mrsny RJ; Parkos CA; Nusrat A
    Mol Biol Cell; 2005 Oct; 16(10):5040-52. PubMed ID: 16055505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of costimulatory molecules CD80 and CD86 and IFNgamma in the pathogenesis of ulcerative colitis.
    Scarpa M; Behboo R; Angriman I; Termini B; Barollo M; Ruffolo C; Polese L; D'Incà R; Sturniolo GC; D'Amico DF
    Dig Dis Sci; 2004; 49(11-12):1738-44. PubMed ID: 15628695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat.
    Sun FF; Lai PS; Yue G; Yin K; Nagele RG; Tong DM; Krzesicki RF; Chin JE; Wong PY
    Inflammation; 2001 Feb; 25(1):33-45. PubMed ID: 11293664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.
    Obermeier F; Kojouharoff G; Hans W; Schölmerich J; Gross V; Falk W
    Clin Exp Immunol; 1999 May; 116(2):238-45. PubMed ID: 10337013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.
    Noguchi M; Hiwatashi N; Liu Z; Toyota T
    Gut; 1998 Aug; 43(2):203-9. PubMed ID: 10189845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease.
    Noguchi M; Hiwatashi N; Liu Z; Toyota T
    J Gastroenterol; 1995 Nov; 30 Suppl 8():52-5. PubMed ID: 8563891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
    Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
    Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive IL-18 expression is up-regulated in Crohn's disease.
    Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
    J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
    Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
    Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.
    Plevy SE; Landers CJ; Prehn J; Carramanzana NM; Deem RL; Shealy D; Targan SR
    J Immunol; 1997 Dec; 159(12):6276-82. PubMed ID: 9550432
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.